Skip to main content
DNA Labs India

SLC33A1 Gene SPG42 NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

SLC33A1 Gene SPG42 NGS Genetic Test

Short Name: SLC33A1 SPG42 NGS Test

Also known as: SLC33A1 Mutation Test, SPG42 Genetic Test, Hereditary Spastic Paraplegia Type 42 Testing

SLC33A1 Gene SPG42 NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in The results are typically available in 3 to 4 weeks after the sample reaches the laboratory. The exact time may vary depending on the sample quality, test complexity, and the need for confirmatory studies.. Free home collection in 300+ cities across India.

Molecular Diagnostics (NGS Single Gene)UnisexAll Ages🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of this NGS genetic test is to detect pathogenic variants in the SLC33A1 gene that cause SPG42, thereby confirming a clinical diagnosis of hereditary spastic paraplegia. Early molecular diagnosis enables prompt initiation of symptomatic therapy, appropriate genetic counselling, carrier testing in family members, and informed family planning decisions.

Test Code
4534
CPT Code
81403
ICD Code
G11.4
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
The results are typically available in 3 to 4 weeks after the sample reaches the laboratory. The exact time may vary depending on the sample quality, test complexity, and the need for confirmatory studies.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. Patients should provide a detailed clinical history including symptom onset, neurological examination findings, and any prior relevant investigations. A genetic counselling session will be conducted to draw a pedigree chart of family members affected with susceptibility to SPG42. Please carry previous medical records and imaging reports if available.

Method: Blood draw / FTA card fingerstick / DNA submission

Step 2

Laboratory Analysis

The sample collection is a simple procedure. For a blood sample, a trained phlebotomist will draw 2-3 ml of peripheral venous blood into an EDTA vacutainer. If using an FTA card, a small drop of blood from a fingerstick will be applied to the card and allowed to dry. For extracted DNA, a minimum of 1 µg of high-quality DNA in a sterile tube is required.

Step 3

Report Delivery

There are no specific post-collection restrictions. Patients may resume normal activities immediately after sample collection. Reports will be delivered within 3-4 weeks and shared through online portal, email, or WhatsApp. A genetic counsellor will explain the results and discuss the next steps.

Timeline: The results are typically available in 3 to 4 weeks after the sample reaches the laboratory. The exact time may vary depending on the sample quality, test complexity, and the need for confirmatory studies.

Patient Instructions

1
Before the Test:Before testing, patients will have a pre-test genetic counselling session. During this session, a clinical geneticist will take a detailed family history, draw a pedigree chart, discuss the purpose, limitations, and possible outcomes of the test, and obtain informed consent. No specific medical preparation is required.
2
During the Test:The procedure involves a simple sample collection, either blood draw, FTA card finger prick, or submission of extracted DNA. There is no pain except for the minor sting of the needle. The sample is then shipped to the DNA Labs India laboratory for NGS analysis.
3
After the Test:After the test, patients can resume normal daily activities. The report will be issued in 3-4 weeks. A genetic counsellor will contact the patient to explain the results, their implications, and the recommended next steps, including any need for clinical follow-up or family testing.

About This Test

Who Should Get This Test

The primary purpose of this NGS genetic test is to detect pathogenic variants in the SLC33A1 gene that cause SPG42, thereby confirming a clinical diagnosis of hereditary spastic paraplegia. Early molecular diagnosis enables prompt initiation of symptomatic therapy, appropriate genetic counselling, carrier testing in family members, and informed family planning decisions.

How to Prepare

  • Blood sample must be collected in an EDTA vacutainer and should not be hemolysed
  • FTA card should be completely dried before placing in the return envelope
  • Extracted DNA sample should be quantified and shipped in a sterile DNA-safe tube
  • Samples should be stored at ambient temperature during transportation and should not be frozen
  • Avoid sample contamination by following standard phlebotomy procedures

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic counselling is vital for individuals with a family history of hereditary spastic paraplegia. This SLC33A1 gene test not only confirms SPG42 but also helps in carrier detection and informed reproductive planning."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml Peripheral Blood / 1-2 drops on FTA Card / 1 µg Extracted DNA
ContainerEDTA Vacutainer / FTA Card / Sterile DNA collection vial
Collection MethodBlood draw / FTA card fingerstick / DNA submission

Sample Stability

Whole blood in EDTA (Room Temperature)48 hours
Whole blood in EDTA (2-8°C)1 week
FTA card (Room Temperature)6 months
Extracted DNA (2-8°C)1 month
Sample Rejection Criteria:
  • Hemolysed or clotted blood sample
  • Insufficient sample volume
  • Improperly labelled sample
  • FTA card with less than the required number of blood spots
  • DNA sample with high degradation or contamination

Understanding Your Results

The SLC33A1 gene NGS test result is reported along with a clinical interpretation based on ACMG guidelines. A 'negative' result indicates no pathogenic variant was detected. A 'positive' result identifies a pathogenic or likely pathogenic variant, confirming the diagnosis of SPG42. Variants of uncertain significance (VUS) require further investigation and family segregation analysis.
📊

No mutation in SLC33A1 gene found. SPG42 is very unlikely, but other hereditary spastic paraplegia genes may be considered.

Result type: Negative (No Pathogenic Variant)

📊

Confirms the diagnosis of SPG42 Hereditary Spastic Paraplegia. Allows for family screening and carrier testing.

Result type: Positive (Pathogenic/Likely Pathogenic Variant)

📊

A genetic variant was identified but its disease association is unclear. Additional family studies or functional analysis may be recommended.

Result type: Variant of Uncertain Significance (VUS)

📊

No disease association; considered normal genetic variation.

Result type: Benign/ Likely Benign Variant

⚠️ When to Consult a Doctor:

Consult a neurologist or clinical geneticist if you or a family member experiences progressive muscle stiffness, walking difficulty, frequent falls, cognitive decline, or any other symptoms suggestive of hereditary spastic paraplegia. Early genetic testing is recommended for affected individuals and at-risk family members.

Limitations

  • This test does not detect large deletions/duplications involving the entire SLC33A1 gene unless specified with CNV analysis
  • Variants in deep intronic regions or complex structural rearrangements may not be detected
  • It does not identify repeat expansion disorders causing other forms of HSP
  • Results should be interpreted in the context of clinical, neurological, and family history

Risks & Considerations

  • No significant physical risks; a simple blood draw may cause mild bruising, swelling, or dizziness
  • Psychological impact of learning a genetic diagnosis
  • Possible identification of variants of uncertain significance that may require additional testing
  • Minor risk of sample mix-up or labelling error (mitigated by standard laboratory procedures)

Interfering Factors

  • Poor quality or degraded DNA sample
  • Presence of large deletion/duplication not covered by standard NGS
  • Incomplete clinical history leading to misinterpretation
  • Variants in intronic or regulatory regions not analyzed

Compare With Similar Tests

TestSLC33A1 Gene SPG42 NGS Genetic TestSLC33A1 Gene SPG42 NGS Genetic TestHereditary Spastic Paraplegia NGS PanelWhole Exome Sequencing (WES)
ComparisonSLC33A1 Gene SPG42 NGS Genetic Test

Frequently Asked Questions

What is the SLC33A1 gene SPG42 NGS genetic test?
This is a targeted Next-Generation Sequencing test that analyses the SLC33A1 gene for mutations associated with SPG42, a rare type of hereditary spastic paraplegia. It helps confirm a clinical diagnosis of SPG42.
How much does the SLC33A1 gene SPG42 genetic test cost at DNA Labs India?
The test cost is INR 20,000. This includes the NGS analysis, clinical report, genetic counselling, and free home sample collection across major Indian cities.
What sample is required for this test?
You can provide 2-3 ml of blood in an EDTA vacutainer, or one drop of blood on an FTA card, or extracted DNA (at least 1 µg). The choice depends on convenience and availability.
Do I need to fast before giving a sample for this genetic test?
No fasting is required. Unlike many blood tests, genetic testing for SLC33A1 does not require an empty stomach. You can eat and drink normally.
How long does it take to get the test report?
The turnaround time is 3 to 4 weeks after the sample reaches the laboratory. Reports are shared through an online portal, email, and WhatsApp as soon as they are ready.
What are the typical symptoms of SPG42?
Common symptoms include muscle stiffness, spasms, difficulty walking, balance problems, weakness or paralysis of leg muscles, cognitive impairment, speech difficulties, and vision problems. Symptoms often begin in childhood but can appear later.
Who should consider getting this genetic test?
Individuals with unexplained spasticity, gait disturbance, or a family history of hereditary spastic paraplegia, especially when SPG42 is suspected, should consider this test. It is also useful for carrier testing and family planning.
How is the test performed?
DNA is extracted from the sample, and the SLC33A1 gene is enriched and sequenced using Next-Generation Sequencing technology. The data is analyzed for pathogenic variants, and a detailed clinical report is generated.
Will I get only the clinical report or also raw data?
DNA Labs India is the only lab that shares raw data (FASTQ and VCF files) along with the conclusive clinical report. This ensures transparency and allows for independent secondary analysis if required.
Is home sample collection available for this test?
Yes, DNA Labs India provides free home sample collection for online bookings across more than 200 cities, including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, and Pune.
Why is genetic counselling important before this test?
Genetic counselling helps draw a family pedigree, understand the risks and benefits of testing, interpret the possible outcomes, and make informed decisions about reproductive planning and family screening. It is an integral part of the testing process.
Can this test help with family planning?
Yes, if a pathogenic variant is found, other family members can undergo carrier testing. In pregnancy, prenatal diagnosis or preimplantation genetic testing can be discussed with a geneticist or gynaecologist.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.